David E. Joyner, Ph.D.
Research Assistant Professor
Specialty: Orthopaedic Research
Master of Science: University of Utah
Doctorate: University of Nebraska
A graduate of the University of Utah (Zoology/Entomology), Dr. Joyner earned a Master of Science degree (Zoology - avian ecology) from the University of Utah in 1968 and completed his Ph.D. in Zoology (avian ecology and behavior) at the University of Nebraska in 1975. Before joining the University of Utah School of Medicine in 1984, he served from 1975 through 1984 as a Zoology faculty member with the universities of Guelph (Ontario) and Southern Illinois University, Carbondale , IL . From 1984 through 2001, David was employed as a Senior Research Specialist in the Division of Experimental Oncology (Dept. Radiology) and as a Research Associate with the Laser Institute (Dept. Surgery) and the Division of Rheumatology (Internal Medicine). David is currently Supervisor of the Sarcoma Array Research Consortium (SARC ™) Laboratory located in the Huntsman Cancer Institute, and was appointed as a Research Instructor in the Dept. of Orthopaedics in 2003. His research interests involve the molecular genetics of sarcomas, and include the processes of programmed cell death (apoptosis) and inter-cellular communication.
Current Publications:
Joyner DE, Aboulafia AJ, Damron TA, Randall RL. Fas Death Pathway in sarcomas correlates with epidermal growth factor transcription. Clin Orthop Relat Res (2008; in press) [abstract]
Joyner DE, Damron TA, Aboulafia AJ, Randall RL. Oncogene coexpression in mesenchymal neoplasia correlates with EGF transcription. Clin Orthop Relat Res 2007; 459: 14-21. [abstract]
Joyner DE, Damron TA, Aboulafia A, Bokor W, Bastar JD, Randall RL. Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia. Tissue Antigens 2006; 68: 19-27. [abstract]
Joyner DE, Bastar JD, Randall RL. Doxorubicin induces cell senescence preferentially over apoptosis in the FU-SY-1 synovial sarcoma cell line. J Orthop Res 2006; 24: 1163-9. [abstract]
